ArticleScientific reports2018

The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice.

Daniel F Manvich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.